Volume 46, Issue 2 pp. 86-91
Full Access

Beta-Propiolactone for the Inactivation of Non-A/Non-B Type 1 Hepatitis Virus Capable of Inducing Cytoplasmic Tubular Ultrastructures in Chimpanzees

H. Yoshizawa

H. Yoshizawa

Hepatitis Division, the Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

Search for more papers by this author
Y. Itoh

Y. Itoh

Hepatitis Division, the Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

Search for more papers by this author
S. Iwakiri

S. Iwakiri

Hepatitis Division, the Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

Search for more papers by this author
K. Kitajima

K. Kitajima

Hepatitis Division, the Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

Search for more papers by this author
Y. Noguchi

Y. Noguchi

Yokohama City Institute of Health, Yokohama, Japan

Search for more papers by this author
K. Tachibana

K. Tachibana

The Japanese Red Cross Blood Center, Tokyo, Japan

Search for more papers by this author
T. Nakamura

T. Nakamura

Institute of Immunology, University of Tokyo, Tokyo, Japan

Search for more papers by this author
Y. Miyakawa

Y. Miyakawa

The Third Department of Internal Medicine, University of Tokyo, Tokyo, Japan

Search for more papers by this author
Dr.M. Mayumi

Corresponding Author

Dr.M. Mayumi

Immunology Division, Jichi Medical School, Tochigi, Japan

Immunology Division, Jichi Medical School, Minamikawachi-Machi, Tochigi-Ken 329–04 (Japan)Search for more papers by this author
First published: February 1984
Citations: 4

Abstract

Non-A/Non-B type 1 hepatitis virus may be recognized because it induces characteristic tubular ultrastructures in the hepatocyte cytoplasm of chimpanzees. 3 chimps received 0.1 ml of a chimp serum containing more than 100 chimp infecting units of non-A/non-B type 1 hepatitis virus after it had been treated with β-propiolactone with or without combined ultraviolet irradiation. All of the chimps escaped infection throughout the observation period of 23 weeks. The treatment of the serum with β-propiolactone at the mildest condition employed (0.05%, 4°C, 20 min) was still effective in inactivating the virus. The susceptibility of the chimps was ascertained by the subsequent challenge with 0.1 ml of the untreated serum which invariably induced non-A/non-B type 1 hepatitis in them. On the basis of these results, β-propiolactone was extremely efficacious for the cold sterilization of non-A/non-B type 1 hepatitis virus.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.